Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-EN
Language French English
Date Updated 2023-04-03 2023-01-03
Drug Identification Number 02244475 02244475
Brand name DIPYRIDAMOLE INJECTION, USP DIPYRIDAMOLE INJECTION, USP
Common or Proper name DIPYRIDAMOLE INJECTION, USP DIPYRIDAMOLE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients DIPYRIDAMOLE DIPYRIDAMOLE
Strength(s) 5MG 5MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 mL 10 mL
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-12-01 2022-12-01
Actual start date 2023-01-01 2022-12-01
Estimated end date 2023-03-31 2023-01-09
Actual end date 2023-02-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product on 100% allocation . Product on backorder.
Health Canada comments